Home » Topics » Regulatory

Regulatory
RSS

Levitra receives FDA approval

Aug. 25, 2003

Health Canada approves Gamunex

Aug. 22, 2003

FDA approves Trileptal for children

Aug. 13, 2003

Lapdap approved by U.K. agency for treatment of P. falciparum malaria

Aug. 11, 2003

FDA approves Photofrin PDT for high-grade dysplasia in Barrett's esophagus

Aug. 6, 2003

Enbrel approved to improve physical function in RA patients

Aug. 5, 2003

Combination therapies for allergic diseases comprising an anti-IgE antibody and antiallergic agent

Aug. 4, 2003

Use of amylin agonists for reducing triglyceride levels

Aug. 4, 2003

FDA approval for Rebetol in pediatric hepatitis C

Aug. 4, 2003

Antiemetic properties reported for known analgesic agent

Aug. 1, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...